BIOMAT Database Logo BIOMAT Database Logo

Synthesis and antimicrobial properties of 2H-pyran-3(6H)-one derivatives and related compounds. 1992

M P Georgiadis, and E A Couladouros, and A K Delitheos
Chemistry Laboratories, Agricultural University of Athens, Greece.

The synthesis of several derivatives of 2H-pyran-3(6H)-ones and their Michael adducts is described. Phenylthio, benzenesulfonyl, p-acetylaminobenzenesulfonyl, and p-bromophenyl substituents are beneficial for activity against gram-positive bacteria. 2-[4-(Phenylthio)phenyl]-2-methyl-6-methoxy-2H-pyran-3(6H)-one (8a) showed a minimum inhibitory concentration of 1.56 micrograms/mL against Staphylococcus aureus ATCC 2593, and 2-[4-(phenylthio)phenyl]-2-methyl-6-[(p-nitrobenzoyl)oxy]-2H-pyran-3 (6H)-one (9) showed a minimum inhibitory concentration of 0.75 microgram/mL against Streptococcus sp. C203M. In general, derivatives of 6-hydroxy-2H-pyran-3(6H)-ones with substituents at C-2 and C-6 showed significant activity against gram-positive bacteria. More specifically, the bulkier the C-2 substituent, the greater the antibacterial activity. Michael adducts of thiols (13) showed activity, which may be due to a retro-Michael reaction. In conclusion, the alpha,beta-enone system is essential for the activity of 6-hydroxy-2H-pyran-3(6H)-ones, and the size and nature of substituents at C-2 are associated with antimicrobial activity.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011753 Pyrones Keto-pyrans.
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

M P Georgiadis, and E A Couladouros, and A K Delitheos
Oxidation of furans. 2. Synthesis and biological properties of 6-hydroxy-2H-pyran-3(6H)-ones and derivatives.
October 1973, Journal of medicinal chemistry,
M P Georgiadis, and E A Couladouros, and A K Delitheos
Sugar-derived 2-S-substituted-2H-pyran-3(6H)-ones: synthesis and reactivity.
September 2005, Carbohydrate research,
M P Georgiadis, and E A Couladouros, and A K Delitheos
5-(Trimethylstannyl)-2H-pyran-2-one and 3-(Trimethylstannyl)-2H-pyran-2-one: New 2H-Pyran-2-one Synthons.
September 1996, The Journal of organic chemistry,
M P Georgiadis, and E A Couladouros, and A K Delitheos
Remarkable O(2)-effect in 1,4-additions of diethylzinc to 6-acyloxy-2H-pyran-3(6H)-ones and 6-alkoxy-2H-pyran-3(6H)-ones
June 2000, Organic letters,
M P Georgiadis, and E A Couladouros, and A K Delitheos
Synthesis and antimicrobial activity of certain 6H-1,2,4-oxadiazin-3(2H)-ones.
January 1977, Journal of medicinal chemistry,
M P Georgiadis, and E A Couladouros, and A K Delitheos
Synthesis and antihypertensive properties of some dopamino-pyridazin-3(2H)-one derivatives.
March 1992, Archiv der Pharmazie,
M P Georgiadis, and E A Couladouros, and A K Delitheos
6-Oxa analogues of pyrimidines and pyrimidine nucleosides. Synthesis of 5-amino-6H-1,2,4-oxadiazin-3(2H)-one, 2-beta-D-ribofuranosyl-6H-1,2,4-oxadiazine-3,5(2H,4H)-dione, and related derivatives.
September 1976, The Journal of organic chemistry,
M P Georgiadis, and E A Couladouros, and A K Delitheos
Simple synthesis of condensed pyran containing compounds and their antimicrobial properties.
January 2001, Bollettino chimico farmaceutico,
M P Georgiadis, and E A Couladouros, and A K Delitheos
Synthesis of isochroman-4-ones and 2H-pyran-3(6H)-ones by gold-catalyzed oxidative cycloalkoxylation of alkynes.
June 2019, Bioorganic & medicinal chemistry,
M P Georgiadis, and E A Couladouros, and A K Delitheos
Design and synthesis of novel tetrahydro-2H-Pyrano[3,2-c]pyridazin-3(6H)-one derivatives as potential anticancer agents.
December 2010, European journal of medicinal chemistry,
Copied contents to your clipboard!